Minimization of ragweed allergy immunotherapy costs through use of the sublingual immunotherapy tablet in Canadian children with allergic rhinoconjunctivitis

BACKGROUND: Allergy immunotherapy (AIT), in the form of subcutaneous immunotherapy (SCIT) with alum-precipitated aqueous extracts, SCIT with a modified ragweed pollen allergen tyrosine adsorbate (MRPATA; Pollinex(®)-R), or a sublingual immunotherapy (SLIT)-tablet are options for the treatment of rag...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellis, Anne K., Mack, Douglas P., Gagnon, Rémi, Hammerby, Eva, Gosain, Sheena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847451/
https://www.ncbi.nlm.nih.gov/pubmed/36653868
http://dx.doi.org/10.1186/s13223-023-00758-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847451/
https://www.ncbi.nlm.nih.gov/pubmed/36653868
http://dx.doi.org/10.1186/s13223-023-00758-7

Ejemplares similares